neonatal outcomes

Use of Antipsychotic Medications in Pregnancy Increases Risk of Gestational Diabetes

Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder.  Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety of these medications. 

By |2024-04-14T16:18:01-04:00July 17th, 2012|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Pregnancy Outcomes|Comments Off on Use of Antipsychotic Medications in Pregnancy Increases Risk of Gestational Diabetes

Measuring the Effects of Antidepressants versus Untreated Depression on Pregnancy Outcomes

Multiple studies have demonstrated an increased risk of poor neonatal adaptation associated with exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy.  Results in the literature consistently indicate that about 25%-30% of infants exposed to SSRIs late in pregnancy manifest symptoms of poor neonatal adaption, including jitteriness, restlessness, increased muscle tone, rapid breathing.  These symptoms are transient, resolving spontaneously with no specific medical intervention.

By |2015-08-12T13:56:55-04:00July 10th, 2012|Depressive Disorders, Outcomes, Psychiatric Disorders During Pregnancy|Comments Off on Measuring the Effects of Antidepressants versus Untreated Depression on Pregnancy Outcomes

Worse outcomes in Infants Exposed to MDMA (Ecstasy) during Pregnancy

3,4-methylenedioxymethamphetamine (MDMA) or “Ecstasy” is one of the most widely used illicit recreational drugs among young adults. This report indicates that infants exposed to Ecstasy ad other recreational drugs may have delays in their motor development.

By |2015-08-12T16:27:24-04:00May 19th, 2012|Child Outcomes, Outcomes, Perinatal Substance Use|Comments Off on Worse outcomes in Infants Exposed to MDMA (Ecstasy) during Pregnancy

Exposure to Antidepressants During Pregnancy and Risk of ADHD in the Offspring

Antenatal exposure to Wellbutrin (bupropion) does not appear to be associated with an increased risk of malformations in the exposed infant; however,  it is not known if exposure to Wellbutrin during pregnancy has any effect on the child’s neurobehavioral development. In a study from Figueroa and colleagues published in 2010, insurance claims data from 38,704 children and their families were analyzed, using information obtained from the beginning of pregnancy until age 5.  Outcomes were assessed in mothers taking selective serotonin reuptake inhibitors (SSRIs) or Wellbutrin before, during or after the pregnancy.  This study sought to determine the risk of ADHD in exposed infants.  Children up to the age of 5 were identified as having ADHD if they had an outpatient or inpatient claim with a primary or secondary diagnosis of ADHD or a prescription claim for stimulants.

By |2020-12-11T12:41:30-04:00May 7th, 2012|Antidepressants, Long-Term Outcomes, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Exposure to Antidepressants During Pregnancy and Risk of ADHD in the Offspring

Prenatal Antipsychotic Exposure and Neuromotor Performance

While a handful of studies have assessed the risk for congenital malformations in infants exposed to antipsychotic agents, there is even less information regarding neonatal outcome in this population.  In 1992, it was first reported that infants exposed to first-generation antipsychotic medications exhibited increased muscle tone, tremulousness, and poor motor functioning when assessed within a few days of delivery.

By |2015-08-12T16:42:15-04:00April 25th, 2012|Antipsychotic Medications, Neonatal Symptoms, Outcomes, Pregnancy & Medications|Comments Off on Prenatal Antipsychotic Exposure and Neuromotor Performance

No Safe Level of Alcohol Use in Pregnancy

Reduced birth length and weight, microcephaly, and characteristic facial deformities (smooth philtrum and thin vermillion border) are associated with alcohol exposure during the second half of the first trimester and are dose-related.  In this prospective study including 992 subjects, there was no evidence of a threshold, indicating that women should be advised to abstain from alcohol consumption from conception throughout pregnancy.

By |2015-08-12T16:50:33-04:00March 12th, 2012|Alcohol, Outcomes, Perinatal Substance Use|Comments Off on No Safe Level of Alcohol Use in Pregnancy

Prenatal Use of Atypical Antipsychotics: Effect on Birth Weight

Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder.  Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data addressing the reproductive safety of these medications.

By |2015-08-12T15:37:11-04:00January 25th, 2010|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Pregnancy Outcomes|Comments Off on Prenatal Use of Atypical Antipsychotics: Effect on Birth Weight

Antenatal Use of SSRIs and QT Interval Prolongation in Newborns

Over the last several years, a number of studies have indicated that exposure to antidepressants near the time of delivery may be associated with poor neonatal outcomes. A recent prospective study from Dubnov-Raz and colleagues published in the journal Pediatrics found an association between QTc interval prolongation in neonates and antenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants.  The QT interval is a measurement of the heart's electrical cycle from ventricular depolarization to the end of ventricular polarization.  It is determined from an electrocardiogram (ECG) and is corrected for heart rate. 

By |2015-08-12T14:14:31-04:00March 24th, 2009|Antidepressants, Neonatal Symptoms, Outcomes, Pregnancy & Medications|Comments Off on Antenatal Use of SSRIs and QT Interval Prolongation in Newborns

Depression during Pregnancy Increases the Risk of Preterm Delivery

A new study reported in Human Reproduction supports what many other studies have found, that untreated depression during pregnancy increases the likelihood of delivering before 37 weeks gestation.

By |2015-08-12T11:47:05-04:00November 3rd, 2008|Depressive Disorders, Outcomes, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy|Comments Off on Depression during Pregnancy Increases the Risk of Preterm Delivery

Accumulating Data on Prenatal Exposure to SSRIs

November, 2006 by LEE COHEN, M.D. Over the last year, several studies on possible neonatal effects of prenatal exposure to SSRIs have been reviewed in this column. These studies have raised concerns about potential risks, [...]

By |2020-12-11T12:38:11-04:00April 29th, 2008|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Accumulating Data on Prenatal Exposure to SSRIs
Go to Top